Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants with Advanced Solid Tumors
GCT1079-01
Phase 1 other active
Quick answer
Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants with Advanced Solid Tumors for Advanced Malignant Solid Tumors is a Phase 1 program (other) at Genmab A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Genmab A/S
- Indication
- Advanced Malignant Solid Tumors
- Phase
- Phase 1
- Modality
- other
- Status
- active